Grufity logoGrufity logo

Danaher Corp Stock Research

DHR

252.04USD+2.24(+0.90%)Market Closed

Market Summary

USD252.04+2.24
Market Closed
0.90%

DHR Stock Price

DHR RSI Chart

DHR Valuation

Market Cap

181.9B

Price/Earnings (Trailing)

25.24

Price/Sales (Trailing)

5.78

EV/EBITDA

19.04

Price/Free Cashflow

24.7

DHR Price/Sales (Trailing)

DHR Profitability

EBT Margin

26.35%

Return on Equity

14.39%

Return on Assets

8.55%

Free Cashflow Yield

4.05%

DHR Fundamentals

DHR Revenue

Revenue (TTM)

31.5B

Revenue Y/Y

2.71%

Revenue Q/Q

9.21%

DHR Earnings

Earnings (TTM)

7.2B

Earnings Y/Y

24.83%

Earnings Q/Q

41.98%

Price Action

52 Week Range

233.47303.82
(Low)(High)

Last 7 days

1.4%

Last 30 days

0.9%

Last 90 days

-5.9%

Trailing 12 Months

-15.9%

DHR Financial Health

Current Ratio

1.89

DHR Investor Care

Shares Dilution (1Y)

1.86%

Diluted EPS (TTM)

9.66

Peers (Alternatives to Danaher)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
181.9B
31.5B
0.92% -15.91%
25.24
5.78
6.85% 12.06%
106.2B
18.4B
6.78% 4.67%
45.05
5.76
7.84% 18.25%
105.3B
30.8B
-4.37% -28.48%
25.91
3.42
-3.19% -17.38%
88.0B
6.2B
9.55% -17.45%
66.52
14.14
8.97% -22.43%
49.6B
5.4B
1.40% -30.34%
32.6
9.22
2.86% 1.25%
MID-CAP
10.6B
847.1M
6.58% 27.77%
-5.3K
12.46
13.32% -137.89%
5.6B
1.0B
-4.49% -25.70%
32.22
5.43
6.76% 24.45%
4.7B
1.6B
1.62% -13.99%
26
3.01
0.99% 6.79%
3.0B
284.4M
12.67% -24.43%
77.64
10.58
23.40% 58.18%
SMALL-CAP
911.6M
222.4M
-3.27% -32.68%
-622.28
4.1
36.07% -119.34%
69.0M
13.1M
39.22% -49.29%
-0.98
5.26
13.64% 4.49%
42.9M
195.0M
-0.59% 6.54%
-16.06
0.22
29.53% 63.61%
8.7M
3.5M
-22.21% -74.59%
-0.65
2.45
44.21% -50.10%
1.8M
10.2M
-20.81% 288.54%
-0.16
0.17
15.89% 6.85%

Financials for Danaher

Income Statement (Last 12 Months)
(In Millions)
* denotes actual numbers (not divided by Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue0.7%31,47131,25030,81630,28329,453
Gross Profit0.0%18,94918,95318,72818,40417,952
  S&GA Expenses-1.2%8,5168,6208,5338,4148,198
  R&D Expenses-2.4%1,7451,7871,8081,8031,742
EBITDA1.4%9,2419,1178,6038,587-
EBITDA Margin0.6%0.29*0.29*1.61*0.28*-
Earnings Before Taxes1.3%8,2928,1847,6407,6147,598
EBT Margin0.6%0.26*0.26*1.43*0.25*-
Interest Expenses3.9%211203223234238
Net Income6.6%7,2096,7656,3516,4566,433
Net Income Margin5.8%0.23*0.22*1.19*0.21*-
Free Cahsflow4.2%7,3677,0687,0517,162-
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets4.1%84,35081,03081,80683,39283,184
  Current Assets11.5%15,88314,25013,22912,67011,648
    Cash Equivalents16.4%5,9955,1503,9843,7172,586
  Inventory-3.9%3,1103,2363,2573,0722,767
  Net PPE6.4%3,9563,7193,7943,8153,790
  Goodwill3.9%39,75238,25139,27640,66341,184
  Current Liabilities4.8%8,3898,0027,5567,5478,140
    LT Debt, Non Current2.9%19,08618,54220,05221,76822,168
Shareholder's Equity6.6%50,08246,98546,59446,35645,167
  Retained Earnings5.5%39,20537,17735,80834,33232,827
  Additional Paid-In Capital0.7%12,07211,98511,85410,12310,090
Accumulated Depreciation2.5%3,6273,5383,5173,465-
Shares Outstanding0.1%728728727716715
Minority Interest0%8.008.007.006.0010.00
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations2.5%8,5198,3118,3358,4558,358
  Share Based Compensation2.1%336329292244218
Cashflow From Investing2.7%-2,234-2,297-11,830-12,497-12,987
Cashflow From Financing16.7%-2,570-3,0864491,4701,295
  Dividend Payments1.5%818806793764742

Risks for DHR

What is the probability of a big loss on DHR?

40%


Probability that Danaher stock will be more than 20% underwater in next one year

0%


Probability that Danaher stock will be more than 30% underwater in next one year.

0%


Probability that Danaher stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does DHR drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Danaher was unfortunately bought at previous high price.

Drawdowns

Returns for DHR

Cumulative Returns on DHR

18.8%


10-Year Cumulative Returns

20%


7-Year Cumulative Returns

21.1%


5-Year Cumulative Returns

21.4%


3-Year Cumulative Returns

What are the long-term rolling returns for DHR?

FIve years rolling returns for Danaher.

Annualized Returns

Which funds bought or sold DHR recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-03-28
Werba Rubin Papier Wealth Management
new
-
331,288
331,288
0.14%
2023-03-24
PALISADE CAPITAL MANAGEMENT, LP
reduced
-10.41
-1,665,740
15,425,300
0.41%
2023-03-24
PALISADE CAPITAL MANAGEMENT, LP
reduced
-0.76
951,246
49,043,200
1.32%
2023-03-23
ETF MANAGERS GROUP, LLC
added
3.85
40,174
644,174
0.03%
2023-03-23
MetLife Investment Management, LLC
reduced
-1.57
517,983
45,839,100
0.37%
2023-03-22
Pictet North America Advisors SA
added
867
1,791,810
1,992,240
0.34%
2023-03-17
American Portfolios Advisors
unchanged
-
1,456
80,849
-%
2023-03-17
American Portfolios Advisors
reduced
-1.24
20,552
3,340,810
0.14%
2023-03-15
B. Riley Wealth Advisors, Inc.
added
2.71
140,066
2,651,070
0.07%
2023-03-10
MATHER GROUP, LLC.
added
21.53
224,379
1,126,380
0.02%

1–10 of 48

Latest Funds Activity

Are funds buying DHR calls or puts?
Calls
Puts
Are funds bullish or bearish(Calls - Puts)?
Net Call Options
No. of funds that own DHR
No. of Funds

Danaher News

MarketWatch

Waters Corp. stock outperforms market on strong trading day.

MarketWatch,
34 minutes ago

MarketWatch

Schedule 13G FIlings of Danaher

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 09, 2023
vanguard group inc
7.48%
54,428,553
SC 13G/A
Jan 31, 2023
blackrock inc.
7.1%
51,630,040
SC 13G/A
Mar 11, 2022
blackrock inc.
6.4%
45,990,561
SC 13G/A
Feb 09, 2022
vanguard group inc
6.99%
49,960,190
SC 13G/A
Feb 08, 2022
blackrock inc.
6.4%
45,990,561
SC 13G
Nov 02, 2021
rales mitchell p
4.99%
35,669,704
SC 13D/A
Jun 14, 2021
rales steven m
6.1%
43,454,958
SC 13D/A
Jun 14, 2021
rales mitchell p
5.0%
35,669,704
SC 13D/A
Feb 16, 2021
price t rowe associates inc /md/
4.4%
31,588,419
SC 13G/A
Feb 10, 2021
vanguard group inc
6.86%
48,739,681
SC 13G/A

DHR Fair Value

Danaher fair value in different scenarios

The table shows the Fair Value estimates for Danaher for various scenarios. Disclaimer: These are just estimations from a model. None of the models are good at predicting the future. Please dont buy or sell stocks based on these outputs.
Fair ValueVery PessimisticPessimisticBase CaseOptimisticVery Optimistic
Very Low Inflation

109.40

-56.59%

140.25

-44.35%

260.92

3.52%

464.42

84.26%

618.07

145.23%
Current Inflation

100.57

-60.10%

127.10

-49.57%

229.20

-9.06%

399.89

58.66%

528.46

109.67%
Very High Inflation

89.63

-64.44%

111.14

-55.90%

192.11

-23.78%

326.01

29.35%

426.53

69.23%

Historical Danaher Fair Value Estimates


Very Pessimistic Case
Pessimistic Case
Fair Value
Optimistic Case
Very Optimistic Case
Closing Stock Price

Recent SEC filings of Danaher

View All Filings
Date Filed Form Type Document
Mar 29, 2023
ARS
ARS
Mar 29, 2023
DEF 14A
DEF 14A
Mar 29, 2023
DEFA14A
DEFA14A
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading
Feb 28, 2023
4
Insider Trading

Latest Insider Trading transactions for DHR

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-02-24
Honeycutt Jennifer
sold (taxes)
-119,328
249
-479
executive vice president
2023-02-24
Gutierrez-Ramos Jose-Carlos
sold (taxes)
-119,827
249
-481
svp, chief science officer
2023-02-24
Bouda Christopher
acquired
-
-
1,004
vp, chief accounting officer
2023-02-24
Couchara Georgeann
sold (taxes)
-81,711
249
-328
svp, human resources
2023-02-24
Weidemanis Joakim
sold (taxes)
-365,459
249
-1,467
executive vice president
2023-02-24
Blair Rainer
sold (taxes)
-505,215
249
-2,028
president & ceo
2023-02-24
McGrew Matthew
sold (taxes)
-155,700
249
-625
evp & chief financial officer
2023-02-24
Raskas Daniel
sold (taxes)
-127,051
249
-510
svp - corporate development
2023-02-24
King William
sold (taxes)
-118,332
249
-475
svp, strategic development
2023-02-24
Bouda Christopher
sold (taxes)
-69,504
249
-279
vp, chief accounting officer

1–10 of 50

Rainer M. Blair
65535
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

DHR Income Statement

2022-12-31
Consolidated Statements of Earnings - USD ($)
shares in Millions, $ in Millions
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]   
Sales$ 31,471$ 29,453$ 22,284
Cost of sales(12,522)(11,501)(9,809)
Gross profit18,94917,95212,475
Operating costs:   
Selling, general and administrative expenses(8,516)(8,198)(6,896)
Research and development expenses(1,745)(1,742)(1,348)
Other operating expenses0(547)0
Operating profit8,6887,4654,231
Nonoperating income (expense):   
Other income (expense), net(226)456494
Loss on early extinguishment of borrowings0(96)(26)
Interest expense(211)(238)(275)
Interest income411171
Earnings from continuing operations before income taxes8,2927,5984,495
Income taxes(1,083)(1,251)(849)
Net earnings from continuing operations7,2096,3473,646
Earnings from discontinued operations, net of income taxes0860
Net earnings7,2096,4333,646
Mandatory convertible preferred stock dividends(106)(164)(136)
Net earnings attributable to common stockholders$ 7,103$ 6,269$ 3,510
Net earnings per common share:   
Net earnings per common share from continuing operations, basic$ 9.80$ 8.65$ 4.97
Net earnings per common share from continuing operations, diluted9.668.504.89
Net earnings per common share from discontinued operations, basic00.120
Net earnings per common share from discontinued operations, diluted00.120
Net earnings per common share, basic9.808.774.97
Net earnings per common share, diluted$ 9.66$ 8.61[1]$ 4.89
Average common stock and common equivalent shares outstanding:   
Basic725.1714.6706.2
Diluted737.1736.8718.7
[1]*    Net earnings per common share amount does not add due to rounding.

DHR Balance Sheet

2022-12-31
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2022
Dec. 31, 2021
Current assets:  
Cash and equivalents$ 5,995$ 2,586
Trade accounts receivable, less allowance for doubtful accounts of $126 as of December 31, 2022 and $124 as of December 31, 20214,9184,631
Inventories3,1102,767
Prepaid expenses and other current assets1,8601,664
Total current assets15,88311,648
Property, plant and equipment, net3,9563,790
Other long-term assets4,4593,719
Goodwill39,75241,184
Other intangible assets, net20,30022,843
Total assets84,35083,184
Current liabilities:  
Notes payable and current portion of long-term debt5918
Trade accounts payable2,2962,569
Accrued expenses and other liabilities5,5025,563
Total current liabilities8,3898,140
Other long-term liabilities6,7857,699
Long-term debt19,08622,168
Stockholders’ equity:  
Preferred stock, no par value, 15.0 million shares authorized; no shares and 1.65 million shares of 4.75% Mandatory Convertible Preferred Stock, Series A, issued and outstanding as of December 31, 2022 and December 31, 2021, respectively; 1.72 million shares of 5.00% Mandatory Convertible Preferred Stock, Series B, issued and outstanding as of December 31, 2022 and December 31, 20211,6683,268
Common stock - $0.01 par value, 2.0 billion shares authorized; 869.3 million issued and 728.3 million outstanding as of December 31, 2022; 855.7 million issued and 715.0 million outstanding as of December 31, 202199
Additional paid-in capital12,07210,090
Retained earnings39,20532,827
Accumulated other comprehensive income (loss)(2,872)(1,027)
Total Danaher stockholders’ equity50,08245,167
Noncontrolling interests810
Total stockholders’ equity50,09045,177
Total liabilities and stockholders’ equity$ 84,350$ 83,184